Leef Brands LEEEF
OTC LEEEF
$0.20 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Leef Brands (LEEEF) EBITDA (2025 - 2026)

Leef Brands (LEEEF) posted EBITDA of $1.3 million for Q1 2026, up 167.29% sequentially from -$1.9 million in Q1 2025, and up 167.29% YoY from $480245.0 in Q1 2025.

Leef Brands (LEEEF) EBITDA (2025 - 2026) Analysis & Trends

Leef Brands has reported EBITDA for 2 years, with the latest figure at $1.3 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.85 Bn 39.19 Bn 2.15 Bn -231.00 Mn
3 Zoetis 31.40 Bn 29.73 Bn 1.05 Bn 837.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 1.26 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 330.80 Mn
6 Viatris 18.71 Bn 17.83 Bn 1.46 Bn 6.30 Mn
7 Neurocrine Biosciences 15.42 Bn 15.03 Bn 935.80 Mn 151.50 Mn
8 Elanco Animal Health 11.70 Bn 11.17 Bn 798.00 Mn 248.00 Mn
9 Dr Reddys Laboratories 10.09 Bn 9.93 Bn - -
10 Leef Brands 59.45 Mn 54.50 Mn 2.41 Mn -1.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.99 Mn
Mar 31, 2026 1.28 Mn
Mar 31, 2025 -1.91 Mn